Home Featured Report

Featured Report

The New landscape
for HCPs in Latin America

Changes in Medical Practice & relationships with Pharma Reps

A new report by Fine Research, the Latin American Healthcare Panel, contains fresh data collected from their ongoing COVID-19 Tracking Study.

A must-read for any researcher and marketer interested in developing communications with doctors in Latin America.

Your report: The new landscape for HCPs in Latin America

By reading this report you will learn latest news such as:

  • 4 out of 10 doctors claim to have introduced new therapies into their practice during pandemic.
  • LatAm HCPs see recovery in number of patients but still show reduced adherence and very low levels of patient controls.
  • Half of LatAm doctors are interested in receiving in-person pharma reps visits now, and 9 out of 10 would like to have them once the pandemic is controlled.

Download the full report to understand the emerging trends and how these vary between different countries and medical specialties.

This report has been featured by The Pharmaceutical Marketing Group.

About the company

Fine Research is the largest medical online panel in Latin America with over 100,000 active participants and running hundreds of surveys annually with HCPs, for the largest market research specialized agencies and supported by its own local teams and offices in Brazil, Mexico, Colombia, Argentina, Chile and Uruguay. For more information please go to www.fine-research.com/blog/news

Since March 2020, Fine Research has been running a series of tracking waves around COVID-19 impact on Healthcare Professionals in Latin America, including over 11.000 interviews in 15 different countries.

Results have been widely published in the press and media in several countries as well as in articles and webinars sponsored by Market Research industry forums such as ESOMAR Foundation, ESOMAR, Research News, EphMRA, Brazilian Association of Research Companies, Brazilian Association of Research professionals, and GreenBook.